TherapeuticsMD (TXMD) Return on Capital Employed Growth (3y) (2015 - 2026)
TherapeuticsMD (TXMD) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | -8,022.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8,022.00 |
| Mar 31, 2026 | -4,116.00 |
| Dec 31, 2025 | -1,497.00 |
| Sep 30, 2025 | -25,332.00 |
| Jun 30, 2025 | -45,773.00 |
| Mar 31, 2025 | -13,052.00 |
| Dec 31, 2024 | -23,747.00 |
| Sep 30, 2024 | 9,251.00 |
| Jun 30, 2024 | 6,236.00 |
| Mar 31, 2024 | 7,044.00 |
| Dec 31, 2023 | 10,811.00 |
| Sep 30, 2023 | 22,526.00 |
| Jun 30, 2023 | 15,592.00 |
| Mar 31, 2023 | 10,919.00 |
| Dec 31, 2022 | 7,559.00 |
| Sep 30, 2022 | 32,306.00 |
| Jun 30, 2022 | 53,489.00 |
| Mar 31, 2022 | 20,769.00 |
| Dec 31, 2021 | 29,171.00 |
| Sep 30, 2021 | -4,722.00 |